COLUMBIA, Md., March 20 /PRNewswire-FirstCall/ -- Martek Biosciences announced today the availability of a new powder form of Martek DHA(TM) for use in food and beverage products requiring dry mixing. Martek DHA powder has much higher concentrations of DHA than fish oil powders currently on the market, leading to easier food formulations because less powder is needed to achieve desired DHA levels. The powder form is available in two DHA concentrations (10% DHA for medium oil load; 17% DHA for high oil load).
“Martek’s new high DHA powder provides food and beverage manufacturers dry mix options for formulation that they have never had before. Martek’s new DHA powder has great stability and sensory characteristics while providing a vegetarian DHA,” stated Martek CEO Henry “Pete” Linsert.
Martek DHA is a vegetarian DHA (docosahexaenoic acid), the key omega-3 fatty acid for brain and eye development and function. Numerous scientific studies demonstrate that people of all ages, from infants to adults, may benefit from an adequate supply of DHA in the diet. Yet, despite its importance, natural food sources of DHA are limited primarily to fatty fish, making it difficult for many people to get enough DHA in their diets.
Made from algae under tightly controlled manufacturing conditions, Martek DHA is free of oceanic contaminants that may be present in certain fish or fish oils. Algae are the only plant source of DHA, a long chain omega-3 fatty acid. Other plant sources of omega-3s, such as flax seed, walnuts and certain vegetable oils, are sources of omega-3s, but do not contain DHA, the omega-3 that supports brain and eye development and function.
Martek Biosciences Corporation is a leader in the innovation and development of omega-3 DHA products that promote health and wellness through every stage of life. The Company produces Martek DHA(TM), a vegetarian omega-3 fatty acid DHA (docosahexaenoic acid), for use in foods, infant formula, and supplements, and ARA (arachidonic acid), an omega-6 fatty acid, for use in infant formula. For more information on Martek Biosciences, visit http://www.martek.com.
This press release contains forward-looking statements regarding the utility, performance and commercialization of Martek’s products. Such statements involve risks and uncertainties that could cause future actual results to differ due to a variety of risk factors, including without limitation those factors set forth in Martek’s filings with the Securities and Exchange Commission.
CONTACT: Martek Biosciences Kyle Stults 410-740-0081
Martek Biosciences Corporation
CONTACT: Kyle Stults of Martek Biosciences Corporation, +1-410-740-0081
Web site: http://www.martekbio.com/
